Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials-Reference-Cited by-同舟云学术

Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials

Published:2020-02-14 Issue:3 Volume:76 Page:288-295
ISSN:0001-5385
Container-title:Acta Cardiologica
language:en
Short-container-title:Acta Cardiologica

Author:

Brockmeyer Maximilian¹,Lin Yingfeng¹,Parco Claudio¹,Karathanos Athanasios¹,Krieger Torben¹,Schulze Volker¹,Heinen Yvonne¹,Bejinariu Alexandru¹,Müller Patrick¹,Makimoto Hisaki¹,Kelm Malte¹²,Wolff Georg¹^ORCID

Affiliation:

1. Medical Faculty, Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Düsseldorf, Germany

2. CARID – Cardiovascular Research Institute Düsseldorf, Düsseldorf, Germany

Funder

Medical Faculty of the Heinrich-Heine-University Düsseldorf

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00015385.2020.1724689

Reference25 articles.

1. Catheter Ablation for Atrial Fibrillation with Heart Failure

2. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation